Daymark Wealth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Sell
624
-2,060
-77% -$871K 0.01% 699
2026
Q1
$1.27M Sell
2,684
-199
-7% -$100K 0.04% 266
2025
Q4
$1.35M Sell
2,883
-438
-13% -$203K 0.04% 245
2025
Q3
$1.42M Sell
3,321
-258
-7% -$100K 0.05% 235
2025
Q2
$1.37M Sell
3,579
-124
-3% -$44.7K 0.05% 223
2025
Q1
$1.28M Buy
3,703
+890
+32% +$286K 0.06% 211
2024
Q4
$844K Buy
2,813
+230
+9% +$80.4K 0.04% 258
2024
Q3
$1.05M Buy
2,583
+279
+12% +$102K 0.04% 239
2024
Q2
$740K Sell
2,304
-657
-22% -$213K 0.03% 277
2024
Q1
$988K Sell
2,961
-37
-1% -$11.3K 0.05% 198
2023
Q4
$811K Buy
2,998
+243
+9% +$60.1K 0.05% 207
2023
Q3
$678K Buy
2,755
+157
+6% +$43K 0.05% 208
2023
Q2
$788K Sell
2,598
-430
-14% -$120K 0.06% 186
2023
Q1
$798K Buy
3,028
+88
+3% +$22.4K 0.11% 151
2022
Q4
$705K Buy
+2,940
New +$658K 0.12% 122

Other funds holding HCA

Daymark Wealth Partners's HCA Position: Q2 2026 in Review

Daymark Wealth Partners reduced its HCA Healthcare (HCA) stake by 77% in Q2 2026, selling an estimated $871K and leaving 624 shares worth $243K. The position accounts for 0.01% of the portfolio, ranked #699.

Daymark Wealth Partners first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.42M in Q3 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Daymark Wealth Partners held 624 shares of HCA Healthcare worth $243K as of Q2 2026.
  • Daymark Wealth Partners sold 2,060 HCA Healthcare shares in Q2 2026, an estimated $871K.
  • HCA Healthcare made up 0.01% of Daymark Wealth Partners's portfolio in Q2 2026, its #699 holding.
  • Daymark Wealth Partners first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Daymark Wealth Partners's HCA Healthcare position peaked at $1.42M in Q3 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.